Concepedia

Shichong Lin

SL

Statistics

Publications

4

Citations

287

H-Index

4

Active since

2018

Affiliations

First Affiliated Hospital of Wenzhou Medical University(Current)

Wenzhou Medical University

Yichun University

Yueqing People's Hospital

Shichong Lin is an author at First Affiliated Hospital of Wenzhou Medical University specializing in pharmacology, oncology, and cancer cell signaling.

ORCID

Publications per year

2018–2019

4

Publications

4

Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway

Lehe Yang, Shichong Lin, Yanting Kang et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 96 citations · Full text

, , +15

Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy

Shichong Lin, Lehe Yang, Yulei Yao et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 77 citations · Full text

, , +17

Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling

Hailun Zheng, Lehe Yang, Yanting Kang et al. · Molecular Carcinogenesis · 2018 · 63 citations

, , +16

<p>Rhein shows potent efficacy against non-small-cell lung cancer through inhibiting the STAT3 pathway</p>

Lehe Yang, Jifa Li, Lingyuan Xu et al. · Cancer Management and Research · 2019 · 51 citations · Full text

, , +13

1–4 of 4